In erdafitinib-resistant bladder cancer cells, high levels of prolyl 4-hydroxylase subunit alpha 2 (P4HA2) stabilize hypoxia inducible factor 1α (HIF-1α), which activates downstream target genes and lowers ROS levels in bladder cancer [53]. Here, P4HA2 is linked to urinary bladder carcinoma.